Navigation Links
Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine
Date:10/24/2007

e): 18.8 months vs. 14.5 months (HR: 0.73; p=0.02). Treatment with TPF resulted in a 27% reduction in the risk of death. In addition, the best overall response to chemotherapy was significantly higher in the Taxotere(R)-based regimen arm compared to the standard arm: 68% (n=120) versus 54% (n=98) (p=0.006).

Patients in the TPF arm compared to the cisplatin and fluorouracil arm (PF) had grade 3/4 neutropenia (76.9% vs. 52.5%), alopecia (11.6% vs. 0%), anemia (9.2% vs. 12.8%) and infection (6.9% vs. 6.1%). Patients receiving the PF regimen had greater grade 3/4 nausea (6.7% vs. 0.6%), vomiting (4.5% vs. 0.6%) and stomatitis (11.2% vs. 4.6%). Commonly seen adverse events in the Taxotere-based regimen included febrile neutropenia (5.2%) and neutropenic infection (13.9%).

The Tax 324 study included not only inoperable patients, but also patients whose tumors were considered potentially operable with low surgical cure or whose tumors were not removed in order to preserve organ function. Patients were randomly assigned to be treated every three weeks for three cycles either with an intravenous infusion of Taxotere 75 mg/m(2) plus cisplatin 100 mg/m(2) on day one and fluorouracil 1000 mg/m(2) per day on days one through four, or the standard therapy, which was intravenous cisplatin 100 mg/m(2) followed by fluorouracil 1000 mg/m(2) per day for five days. Both groups of patients were then given concomitant weekly chemotherapy and radiation therapy for seven weeks. Surgery was performed for those patients considered candidates at the end of the above treatment sequence.

Median overall survival (the primary end point of the study) was significantly improved for patients treated with the Taxotere-based therapy: 71 months vs. 30 months for patients receiving the standard treatment, with a relative risk of death that was 30% lower (HR 0.70; p=0.006). This represents a more than three year absolute improvement in median overall survival. The probability to survive
'/>"/>

SOURCE sanofi-aventis
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
2. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
3. Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
4. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
5. Insmed Inc. Welcomes Studies Linking IGFBP-3 to Prevention of Blindness in Premature Infants
6. Resveratrol Studies Suggest Broad Implications for SIRT1 Activation in Neurodegenerative Diseases of Aging Such as Alzheimers Disease
7. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
8. Phosphagenics Announces Positive Proof of Concept Results from Studies Utilizing Companys Dermal Drug Delivery Technology
9. New Data from Multiple Studies Show Galvus Delivers Consistent and Robust Blood Sugar Control in Patients with Type 2 Diabetes
10. Eurands Zentase Effective in Treating Exocrine Pancreatic Insufficiency, Studies Show
11. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... DIEGO and BOSTON , ... leader in instrument development, custom automation, and contract manufacturing, ... of the Nanopatch™ needle-free drug delivery technology, have been ... development of the Nanopatch Jet Coating Instrument , ... delivery research and product development.  The award was announced ...
(Date:5/29/2015)... , May 29, 2015 /CNW/ - Covalon Technologies Ltd. ... medical technologies company, is delighted to announce its ... 31, 2015, which includes revenue for three months ... of $264,340. Revenue from advanced wound care product sales ... 2015 increased 24% to $1,742,672 compared to $1,400,065 ...
(Date:5/29/2015)... British Columbia and MENLO ... -- DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ... on developing and commercializing proven cancer therapies in ... at the American Association of Cancer Research ... on the potential for its lead product candidate ...
Breaking Medicine Technology:Invetech And Vaxxas Named Recipients Of The 2015 Good Design Award For Development Of Nanopatch Jet Coating Instrument For Needle-Free Drug Delivery 2Invetech And Vaxxas Named Recipients Of The 2015 Good Design Award For Development Of Nanopatch Jet Coating Instrument For Needle-Free Drug Delivery 3Covalon Announces Strong Second Quarter Results 2Covalon Announces Strong Second Quarter Results 3DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 2DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 3DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 4DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 5
... ALEXANDRIA, Va., April 16, 2012 Thirty years ... was passed, enabling tens of millions of Americans ... at life,s end from the nation,s dedicated hospice ... the most compassionate corps of trained volunteers seen ...
... PITTSBURGH, April 16, 2012  Mastech Holdings, Inc. (NYSE ... provider of Information Technology and Specialized Healthcare Staffing services, has scheduled ... first quarter ended March 31, 2012.  The conference ... at 9:00 a.m. Eastern Time and will be ...
Cached Medicine Technology:Thirty Years Since Medicare Hospice Legislation Recognized Value of Hospice Volunteers 2Mastech Holdings, Inc. to Discuss First Quarter 2012 Financial Results on April 25, 2012 2
(Date:5/29/2015)... 2015 Ready to hit the road? Before ... drivers to get their vehicles ready. With handicapped vehicles, there ... Driving Systems (ADS) is ready to help drivers get their ... summer road trips. , When planning for the big trip, ... that the trip goes smoothly and they are prepared for ...
(Date:5/29/2015)... Island (PRWEB) May 29, 2015 The ... 2015. The event, now closed to new registration, starts ... Adams. This exciting competitive running event demonstrates the ... to create a public benefit – in this case, ... coastal views around the famed Ocean Drive and passes ...
(Date:5/29/2015)... CA (PRWEB) May 29, 2015 The science ... in the last decade. New and more efficient methods of ... available to balding patients. One of the most cutting edge ... Mohebi Hair Restoration is the technique of extracting hair from ... scalp transplants are performed to correct male pattern baldness. ...
(Date:5/29/2015)... 2015 Red Hot & Blue Restaurants ... Hot & Blue restaurant at 525 New Waverly Place in ... 2015. “The Red Hot & Blue Restaurant was previously located ... we have moved to a new location in the center,” ... of all the activities on the Promenade–with outdoor seating and ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 The ... the graduates of its Advanced Training Program (ATP) ... who fill roles in their health care organization ... theory and methodology of continuous quality improvement in ... sister-program to Dr. Brent James’ internationally recognized Advanced ...
Breaking Medicine News(10 mins):Health News:Advanced Driving Systems Offers Tips for Summer Road Trips 2Health News:Advanced Driving Systems Offers Tips for Summer Road Trips 3Health News:The Newport 10 Miler at Fort Adams, an Outstanding Example of Event Marketing Helping in Preservation, is Now Completely Booked for 2015 2Health News:The Newport 10 Miler at Fort Adams, an Outstanding Example of Event Marketing Helping in Preservation, is Now Completely Booked for 2015 3Health News:Beard to Scalp Hair Transplant: Newest Advance in Hair Transplant Technology 2Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 2Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 3Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 4Health News:HORNE LLP’s Healthcare Delivery Institute Graduates Class from the Advanced Training Program 2
... Health Market Science,(HMS) has been named to Deloitte,s ... ranking of the 50 fastest growing technology,media, telecommunications ... & Touche USA LLP, one of the nation,s ... percentage revenue growth,over five years from 2002-2006. The ...
... Jack Group, Inc.,(MattsonJack) announces the release of its ... help clients make strategic,decisions based on an in-depth ... conditions. Comorbidity Database(TM) consists of,two modules: Comorbidity Database(TM) ... and Comorbidity Database(TM) -- Med 2.0, which features ...
... the Board of Governors Gene Therapeutics Research Institute at ... that it is possible to sustain therapeutic gene expression ... year, even in the presence of an anti-viral immune ... , The researchers demonstrated in an animal model that ...
... Therapeutics Inc.,("Transition") (NASDAQ: TTHI , TSX: TTH) ... half of the US$15 million upfront payment,under the ... Corporation, plc ("Elan") (NYSE: ELN ) for ... completed Phase I clinical trials and the drug,candidate ...
... One of the nation,s largest and most respected radiology ... with AMICAS to revolutionize radiology IT solutions, ... AMCS ),a leader in radiology and medical image and ... new enterprise agreement,with Radiology Ltd. of Tucson, AZ. ...
... 26 People with,diabetes who have asymptomatic heart disease ... to their hearts without surgical intervention, according,to a study ... which,comes out on October 26, 2007., Researchers found ... aggressively treated their cardiac risk factors with,medication were able ...
Cached Medicine News:Health News:Health Market Science Ranked Number Ten in Deloitte's Technology Fast 50 Program for Greater Philadelphia 2Health News:Health Market Science Ranked Number Ten in Deloitte's Technology Fast 50 Program for Greater Philadelphia 3Health News:The Mattson Jack Group, Inc. Announces the Release of the New Comorbidity Database(TM) 2Health News:Transition Therapeutics Receives Remaining Upfront Payment from Elan Corporation, plc 2Health News:Radiology Ltd. Chooses AMICAS as End-to-End Solutions Provider 2Health News:Radiology Ltd. Chooses AMICAS as End-to-End Solutions Provider 3Health News:Aggressively Treating Cardiac Risk Factors May Reverse Ischemia 2
... are automated, easy to operate and maintain. ... environment by flexible snap-seal pockets which minimize ... contamination of the water. Offered in two-, ... also accommodate bags of various sizes. ThermoLine ...
... thawing systems are automated, easy to operate ... the outside environment by flexible snap-seal pockets ... or viral contamination of the water. Offered ... systems can also accommodate bags of various ...
Conventional Digitally-Controlled Water Baths...
Dry thaws. Has an ingenious (pat. pending) massaging sytem that utilizes the tempered bladders as hands. There are no unreliable mechanical parts involved. Two pumps pressurize different segments of ...
Medicine Products: